Kadoaki Ohashi
- Pulmonary and Respiratory Medicine top 1%
- Oncology top 1%
- Molecular Biology top 10%
- Cancer Research top 5%
- Pathology and Forensic Medicine top 5%
- Co-authors
- William PaoFranziska MichorYosef E. MaruvkaKatsuyuki KiuraEiki IchiharaKatsuyuki HottaToshio KuboNagio Takigawa
- Topics
- Lung Cancer Treatments and Mutations (98 papers)Colorectal Cancer Treatments and Studies (34 papers)Lung Cancer Research Studies (34 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Kadoaki Ohashi
119 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Pulmonary and Respiratory Medicine 1.8k
- Oncology 1.7k
- Molecular Biology 880
- Cancer Research 541
- Pathology and Forensic Medicine 226
Countries citing papers authored by Kadoaki Ohashi
This map shows the geographic impact of Kadoaki Ohashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kadoaki Ohashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kadoaki Ohashi more than expected).
Fields of papers citing papers by Kadoaki Ohashi
This network shows the impact of papers produced by Kadoaki Ohashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kadoaki Ohashi. The network helps show where Kadoaki Ohashi may publish in the future.
Co-authorship network of co-authors of Kadoaki Ohashi
This figure shows the co-authorship network connecting the top 25 collaborators of Kadoaki Ohashi. A scholar is included among the top collaborators of Kadoaki Ohashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kadoaki Ohashi. Kadoaki Ohashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 0 | |
| 8 | 0 | |
| 9 | 1 | |
| 10 | 13 | |
| 11 | 0 | |
| 12 | Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study | 8 |
| 13 | 31 | |
| 14 | 11 | |
| 15 | 109 | |
| 16 | 16 | |
| 17 | HER2 Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in EGFR -Mutant Lung Cancers That Lack the Second-Site EGFR T790M Mutationbreakdown → | 555 |
| 18 | 17 | |
| 19 | 17 | |
| 20 | Emergence of the EGFR T790M mutation in a lung adenocarcinoma cell line after vandetanib treatment | 0 |
About Kadoaki Ohashi
Kadoaki Ohashi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 135 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (98 papers), Colorectal Cancer Treatments and Studies (34 papers) and Lung Cancer Research Studies (34 papers). The work is most often cited by research in Oncology (1.7k citations), Pulmonary and Respiratory Medicine (1.8k citations) and Cancer Research (541 citations). Kadoaki Ohashi has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include William Pao, Franziska Michor, Yosef E. Maruvka, Katsuyuki Kiura, Eiki Ichihara, Katsuyuki Hotta, Toshio Kubo, Nagio Takigawa, Mitsune Tanimoto and Takashi Ninomiya. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.